🇺🇸 FDA
Patent

US 10800749

Centrally active and orally bioavailable antidotes for organophosphate exposure and methods for making and using them

granted A61KA61K31/55A61P

Quick answer

US patent 10800749 (Centrally active and orally bioavailable antidotes for organophosphate exposure and methods for making and using them) held by The Regents of the University of California expires Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Oct 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/55, A61P, A61P25/00